Quarterly pharmacy formulary change notice

Similar documents
Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

3 Tier Formulary Additions

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Aetna Better Health of Illinois Medicaid Formulary Updates

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

Health Partners Medicare Prime 2019 Formulary Changes

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Quarterly pharmacy formulary change

Step Therapy Requirements

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Quarterly Pharmacy Formulary Change Notice

ACYCLOVIR OINT (CCHP2017)

Step Therapy Criteria

ACYCLOVIR OINT (CCHP2017)

2018 CareOregon Advantage Part D Formulary Changes

ACYCLOVIR OINT (CCHP2017)

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

Quarterly pharmacy formulary change notice

Emblem Medicaid 3Q18 Formulary Updates

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

See Important Reminder at the end of this policy for important regulatory and legal information.

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

Neighborhood Medicaid Formulary Changes: June 2017

Drug Class Monograph

Pharmacy Updates Summary

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

Amerigroup Washington, Inc. to conduct postservice reviews of certain modifiers and services

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

Updates to your prescription benefits

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria

Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017

Date: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes

Tribute 2018 Formulary 2018 Quantity Limit Criteria

San Francisco Health Plan (SFHP)

Pharmacy Updates Summary

EFFECTIVE 01/04/2019. pimecrolimus 1 % cream (g) - Added to Tier 1 - ST Added: TOPICAL IMMUNOMODULATORS

WVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions

WellCare s South Carolina Preferred Drug List Update

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

UPDATE Ohana QUEST Integration Medicaid

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

2019 Drug List Negative Changes

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)

1, 2014 PHARMACY BENEFIT

2014 Quantity Limits (QL) Criteria

Calgary Long Term Care Formulary

Tribute 2018 Formulary 2018 Quantity Limit Criteria

ICP Formulary Updates

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Calgary Long Term Care Formulary

Key features and changes to these four components of asthma care include:

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Step Therapy Requirements

HEALTH SHARE/PROVIDENCE (OHP)

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Aspirin. Iron Supplements

Clinical Policy: Roflumilast (Daliresp) Reference Number: CP.PMN.46 Effective Date: Last Review Date: 08.18

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml

See Important Reminder at the end of this policy for important regulatory and legal information.

Transcription:

Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October 1, 2018, the changes outlined below apply to all Anthem Blue Cross and Blue Shield Healthcare Solutions (Anthem) members. Effective for all members on October 1, 2018 Therapeutic class Drug Revised status DIABETIC SUPPLIES DIABETIC SUPPLIES HIV THERAPY PROTON PUMP INHIBITORS (PPI) BD PEN NEEDLES BD INSULIN SYRINGES ALL OTHER PEN NEEDLES AND INSULIN SYRINGES/MANUFACTURERS CIMDUO 300-300 MG SYMFI 600-300-300 MG TROGARZO 200 MG/1.33 ML VIAL BRAND PRILOSEC OTC 20 MG BRAND PRILOSEC OTC 20.6 MG BRAND OTC NEXIUM 24HR 20 MG CAPSULE EDITS NON- WITH STEP THERAPY (ST) COVERED Potential alternatives BD PEN NEEDLES BD INSULIN SYRINGES NO CHANGES IN /NON- STATUS REVISION OR ADDITION TO UM EDIT ONLY ADHD METHYLPHENIDATE ER 72 MG TAB ADD QUANTITY LIMIT (QL) FRAGMIN 2,500 UNITS/0.2 ML SYR FRAGMIN 5,000 UNITS/0.2 ML SYR FRAGMIN 7,500 UNITS/0.3 ML SYR FRAGMIN 10,000 UNITS/ML SYR FRAGMIN 12,500 UNITS/0.5 ML FRAGMIN 15,000 UNITS/0.6 ML 6 ML (30 SYRINGES) PER 30 9 ML (30 SYRINGES) PER 30 30 ML (30 SYRINGES) PER 30 15 ML (30 SYRINGES) PER 30 18 ML (30 SYRINGES) PER 30 https://mediproviders.anthem.com/nv Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc., an independent licensee of the Blue Cross and Blue Shield Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. ANVPEC-0765-18 August 2018

ANTIHYPERTENSIVES DRUGS ANTIPARASITICS ANTIPARASITICS APPETITE STIMULATOR ASTHMA BOWEL PREP CML Anthem Blue Cross and Blue Shield Healthcare Solutions Page 2 of 5 FRAGMIN 18,000 UNITS/0.72 ML 22ML (30 SYRINGES) PER 30 FRAGMIN 25,000 UNITS/3.8 ML VL 22.8 ML (6 VIALS) PER 30 TEKTURNA 37.5MG ORAL PELLETS 8 PELLETS PER DAY IMBRUVICA 140 MG CAPSULE 4 CAPSULE PER DAY IMBRUVICA 70 MG CAPSULE 1 CAPSULE PER DAY IMBRUVICA 140 MG ALBENZA 200 MG IMPAVIDO 50 MG CAPSULE 84 CAPSULES PER FILL 1 FILL EVERY 30 MEGESTROL PA REQUIRED MEGESTROL ORAL SUSP BREO ELLIPTA 200-25 MCG INH BREO ELLIPTA 100-25 MCG INH FLUTICASONE-SALMETEROL 55-14 FLUTICASONE-SALMETEROL 113-14 FLUTICASONE-SALMETEROL 232-14 REMOVING REQUIREMENT FOR DULERA 100 MCG/5 MCG INHALER ICS BEFORE ICS/LABA STEP DULERA 200 MCG/5 MCG INHALER THERAPY AIRDUO RESPICLICK 55-14 MCG AIRDUO RESPICLICK 113-14 MCG EFFECTIVE DATE 08.01.18 AIRDUO RESPICLICK 232-14 MCG ADVAIR 100-50 DISKUS STEP THERAPY FOR T/F OF ADVAIR 250-50 DISKUS ICS/LABA STILL ADVAIR 500-50 DISKUS REQUIRED ADVAIR HFA 115-21 MCG INHALER ADVAIR HFA 45-21 MCG INHALER ADVAIR HFA 230-21 MCG INHALER SYMBICORT 80-4.5 MCG INHALER SYMBICORT 160-4.5 MCG INHALER CLENPIQ SOLUTION 320 MLS PER 30 BEXAROTENE 75 MG CAPSULE 10 CAPSULES PER DAY CABOMETYX 20 MG ZYKADIA 150 MG CAPSULE 3 CAPSULES PER DAY TASIGNA 50 MG CAPSULE 4 CAPSULES PER DAY

DERMATOLOGICAL EPINEPHRINE GLUCOSE ELEVATING Anthem Blue Cross and Blue Shield Healthcare Solutions Page 3 of 5 QUINJA 1.25%-1% GEL AUVI-Q 0.1 MG AUTO-INJECTOR GLUCAGEN 1 MG EMERGENCY KIT ULORIC 40 MG ULORIC 80 MG ZURAMPIC 200 MG KRYSTEXXA 8 MG/ML VIAL DEMSER 250 MG CAPSULE DIBENZYLINE 10 MG CAPSULE KAPSPARGO SPRINKLE PREXXARTAN 60 GMS PER 30 1 BOX (2 PENS) PER FILL 2 KITS IN 30 2 VIALS (2ML) PER 28 16 CAPSULES PER DAY 12 CAPSULES PER DAY 1 CAPSULE PER DAY 80 MLS PER DAY IBD STEROIDS UCERIS 2 MG RECTAL FOAM GLAUCOMA GLAUCOMA GLAUCOMA GLAUCOMA GLAUCOMA GLAUCOMA INTRANASAL STEROIDS MENOPAUSAL THERAPIES AZOPT 1% EYE DROPS BETIMOL 0.25% EYE DROPS BETIMOL 0.5% EYE DROPS RHOPRESSA 0.02% OPHTH SOLUTION TIMOPTIC-XE 0.25% AND 0.5% EYE GEL-SOLN TIMOPTIC OCUMETER PLUS 0.25% AND 0.5 %GEL FORMING SOLN TIMOPTIC 0.25% AND 0.5% OCUDOSE DROP TIMOPTIC OCUMETER PLUS 0.25% AND 0.5% SOLN VYZULTA 0.024% OPHTH SOLUTION XHANCE 93 MCG NASAL SPRAY IMVEXXY 10 MCG VAGINAL INSERT IMVEXXY 4 MCG VAGINAL INSERT 15 MLS PER 30 15 MLS PER 30 5 MLS PER 30 5 MLS PER 30 10 MLS PER 30 2.5 MLS PER 30 2 INHALERS PER 30 18 VAGINAL INSERTS PER 28

Page 4 of 5 MIGRAINE MIGRAINE GASTROINTESTINAL HEPATITIS B INTERFERON ANTIVIRAL THERAPY NEUROPATHIC PAIN AND FIBROMYALGIA NON-NARCOTIC ANALGESIC NSAIDS PHOSPHATE BINDERS PRENATAL VITAMINS PROGESTINS PROSTATE CANCER PROSTATE CANCER ANTIBACTERIALS ANTI- INFECTIVES AIMOVIG 70 MG DOSE-2 AUTOINJ AIMOVIG 140 MG DOSE-2 AUTOINJ SAMSCA 15 MG SAMSCA 30 MG RECTIV 0.4% OINTMENT PEGASYS (PEGINTERFERON ALFA 2A) INTRON A (INTERFERON ALFA 2B) ZTLIDO FIORINAL 50-325-40 MG CAPSULE BUTALBITAL-ASA-CAFFEINE CAP BUTALB-ASPIRIN-CAFFE 50-325-40 BUTALBITAL-ASA-CAFFEINE CAP CONSENSI CALCIUM ACETATE 668 MG NESTABS ONE SOFTGEL MAKENA 275 MG/1.1 ML AUTOINJCT ERLEADA 60 MG YONSA 125 MG ALTABAX 1% OINTMENT XEPI 1 AUTOINJECTOR/1 PACK PER 30 2 AUTOINJECTORS/1 PACK PER 30 2 S PER DAY 30GM TUBE EVERY 30 REMOVE PA REQUIREMENTS 3 PATCHES PER DAY 6 S PER DAY 12 S PER DAY 4 AUTOINJECTORS PER 28 30GM PER FILL 1 FILL PER 30 45 GMS PER FILL 1 FILL PER 30

Page 5 of 5 CORTICOSTEROIDS LOW POTENCY CORTICOSTEROIDS- VERY HIGH POTENCY SYNALAR 0.025% OINTMENT KIT IMPOYZ 0.025% CREAM 1 KIT PER 30 112 GM PER 30 What action do I need to take? Please review these changes and work with your Anthem patients to transition them to formulary alternatives. If you determine preferred formulary alternatives are not clinically appropriate for specific patients, you will need to obtain prior authorization (PA) to continue coverage beyond the applicable effective date. What if I need assistance? We recognize the unique aspects of patients cases. If for medical reasons your Anthem patient cannot be converted to a formulary alternative, call our Pharmacy department at 1-844-396-2330 and follow the voice prompts for pharmacy PA. You can find the Preferred Drug List on our provider website at https://mediproviders.anthem.com/nv. If you need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-844-396-2330.